EUROFINS SCIENTIFIC (ESF0.DE) Fundamental Analysis & Valuation

FRA:ESF0 • FR0014000MR3

Current stock price

61.54 EUR
-1.32 (-2.1%)
Last:

This ESF0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ESF0.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ESF0 was profitable.
  • In the past year ESF0 had a positive cash flow from operations.
  • ESF0 had positive earnings in each of the past 5 years.
  • ESF0 had a positive operating cash flow in each of the past 5 years.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ESF0's Return On Assets of 3.73% is in line compared to the rest of the industry. ESF0 outperforms 42.11% of its industry peers.
  • ESF0's Return On Equity of 9.02% is fine compared to the rest of the industry. ESF0 outperforms 63.16% of its industry peers.
  • With a decent Return On Invested Capital value of 9.81%, ESF0 is doing good in the industry, outperforming 73.68% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESF0 is in line with the industry average of 9.20%.
  • The last Return On Invested Capital (9.81%) for ESF0 is above the 3 year average (8.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 9.81%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a Profit Margin value of 6.06%, ESF0 is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of ESF0 has declined.
  • ESF0 has a Operating Margin (16.10%) which is comparable to the rest of the industry.
  • ESF0's Operating Margin has declined in the last couple of years.
  • ESF0 has a Gross Margin of 24.29%. This is amonst the worse of the industry: ESF0 underperforms 84.21% of its industry peers.
  • ESF0's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. ESF0.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
  • Compared to 1 year ago, ESF0 has less shares outstanding
  • Compared to 5 years ago, ESF0 has less shares outstanding
  • Compared to 1 year ago, ESF0 has a worse debt to assets ratio.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.53 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.53, ESF0 is in line with its industry, outperforming 47.37% of the companies in the same industry.
  • ESF0 has a debt to FCF ratio of 5.14. This is a neutral value as ESF0 would need 5.14 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.14, ESF0 is doing good in the industry, outperforming 68.42% of the companies in the same industry.
  • A Debt/Equity ratio of 0.82 indicates that ESF0 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ESF0 (0.82) is worse than 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.53
ROIC/WACC1.14
WACC8.58%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • ESF0 has a Current Ratio of 1.09. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • ESF0 has a Current ratio (1.09) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.03 indicates that ESF0 should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, ESF0 is in line with its industry, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. ESF0.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • Measured over the past years, ESF0 shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.15% on average per year.
  • ESF0 shows a decrease in Revenue. In the last year, the revenue decreased by -2.80%.
  • ESF0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.43% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%

3.2 Future

  • ESF0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
  • The Revenue is expected to grow by 7.47% on average over the next years.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. ESF0.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.54, the valuation of ESF0 can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 73.68% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.71. ESF0 is valued slightly cheaper when compared to this.
  • ESF0 is valuated correctly with a Price/Forward Earnings ratio of 15.77.
  • 73.68% of the companies in the same industry are more expensive than ESF0, based on the Price/Forward Earnings ratio.
  • ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.54
Fwd PE 15.77
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 78.95% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaply inside the industry as 94.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13
EV/EBITDA 8.2
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ESF0 does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as ESF0's earnings are expected to grow with 13.96% in the coming years.
PEG (NY)1.99
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%

6

5. ESF0.DE Dividend Analysis

5.1 Amount

  • ESF0 has a Yearly Dividend Yield of 1.17%.
  • ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.54. ESF0 pays more dividend than 89.47% of the companies in the same industry.
  • ESF0's Dividend Yield is slightly below the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

  • On average, the dividend of ESF0 grows each year by 16.09%, which is quite nice.
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ESF0 pays out 26.80% of its income as dividend. This is a sustainable payout ratio.
  • ESF0's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

ESF0.DE Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

FRA:ESF0 (3/13/2026, 7:00:00 PM)

61.54

-1.32 (-2.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.21B
Revenue(TTM)6.76B
Net Income(TTM)409.70M
Analysts72
Price Target72.63 (18.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.21%
PT rev (3m)10.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 16.54
Fwd PE 15.77
P/S 1.66
P/FCF 13
P/OCF 8.01
P/B 2.47
P/tB N/A
EV/EBITDA 8.2
EPS(TTM)3.72
EY6.04%
EPS(NY)3.9
Fwd EY6.34%
FCF(TTM)4.73
FCFY7.69%
OCF(TTM)7.68
OCFY12.48%
SpS37.09
BVpS24.94
TBVpS-4.41
PEG (NY)1.99
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 12.72%
ROIC 9.81%
ROICexc 10.81%
ROICexgc 34.71%
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
FCFM 12.76%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ROICexc(3y)9.6%
ROICexc(5y)11.01%
ROICexgc(3y)30.56%
ROICexgc(5y)36.02%
ROCE(3y)11.39%
ROCE(5y)13.27%
ROICexgc growth 3Y-1.05%
ROICexgc growth 5Y-8.2%
ROICexc growth 3Y1.16%
ROICexc growth 5Y-4.51%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.05
Cap/Depr 74.23%
Cap/Sales 7.94%
Interest Coverage 9.42
Cash Conversion 77.25%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.53
F-Score6
WACC8.58%
ROIC/WACC1.14
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)8%
Cap/Sales(5y)8.27%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
EBIT growth 1Y4.52%
EBIT growth 3Y1.62%
EBIT growth 5Y1.23%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ESF0.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 16.54 and the Price/Book (PB) ratio is 2.47.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 6 / 10 and the dividend payout ratio is 26.8%.